Sustained hyperglycemia and impaired insulin signaling in T2DM patients potentiate amyloidogenic processing while compromising tau protein homeostasis, thereby accelerating the neuropathological cascade characteristic of AD progression (43). Here, MAPT is linked to Alzheimer disease.